"Cardiotoxicity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Damage to the heart or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.
| Descriptor ID |
D066126
|
| MeSH Number(s) |
C23.550.161 C25.100.389 C26.733.266 G01.750.748.500.266
|
| Concept/Terms |
Cardiotoxicity- Cardiotoxicity
- Cardiotoxicities
- Cardiac Toxicity
- Cardiac Toxicities
- Toxicities, Cardiac
- Toxicity, Cardiac
|
Below are MeSH descriptors whose meaning is more general than "Cardiotoxicity".
Below are MeSH descriptors whose meaning is more specific than "Cardiotoxicity".
This graph shows the total number of publications written about "Cardiotoxicity" by people in this website by year, and whether "Cardiotoxicity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cardiotoxicity" by people in Profiles.
-
Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst. 2021 05 04; 113(5):513-522.
-
Society for Cardiovascular Magnetic Resonance 2019 Case of the Week series. J Cardiovasc Magn Reson. 2021 04 01; 23(1):44.
-
Ibrutinib's Cardiotoxicity-An Opportunity for Postmarketing Regulation. JAMA Oncol. 2021 02 01; 7(2):177-178.
-
Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease. Curr Cardiol Rep. 2020 09 23; 22(11):151.
-
Personalized Approach to Cancer Treatment-Related Cardiomyopathy. Curr Heart Fail Rep. 2020 04; 17(2):43-55.
-
Risk factors for chemotherapy-related cardiac toxicity. Curr Opin Cardiol. 2019 05; 34(3):283-288.
-
Determining the genetic basis of anthracycline-cardiotoxicity by molecular response QTL mapping in induced cardiomyocytes. Elife. 2018 05 08; 7.
-
A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence. Oncotarget. 2016 Nov 08; 7(45):72443-72457.
-
Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer. Biomed Res Int. 2016; 2016:9363951.